E-resources
-
Lorza, Andres M Arias; Ravi, Harshan; Philip, Rohit C; Galons, Jean-Philippe; Trouard, Theodore P; Parra, Nestor A; Von Hoff, Daniel D; Read, William L; Tibes, Raoul; Korn, Ronald L; Raghunand, Natarajan
Scientific reports, 09/2020, Volume: 10, Issue: 1Journal Article
The vascular disrupting agent crolibulin binds to the colchicine binding site and produces anti-vascular and apoptotic effects. In a multisite phase 1 clinical study of crolibulin (NCT00423410), we measured treatment-induced changes in tumor perfusion and water diffusivity (ADC) using dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DW-MRI), and computed correlates of crolibulin pharmacokinetics. 11 subjects with advanced solid tumors were imaged by MRI at baseline and 2-3 days post-crolibulin (13-24 mg/m ). ADC maps were computed from DW-MRI. Pre-contrast T maps were computed, co-registered with the DCE-MRI series, and maps of area-under-the-gadolinium-concentration-curve-at-90 s (AUC ) and the Extended Tofts Model parameters k , v , and v were calculated. There was a strong correlation between higher plasma drug Formula: see text and a linear combination of (1) reduction in tumor fraction with Formula: see text mM s, and, (2) increase in tumor fraction with Formula: see text. A higher plasma drug AUC was correlated with a linear combination of (1) increase in tumor fraction with Formula: see text, and, (2) increase in tumor fraction with Formula: see text. These findings are suggestive of cell swelling and decreased tumor perfusion 2-3 days post-treatment with crolibulin. The multivariable linear regression models reported here can inform crolibulin dosing in future clinical studies of crolibulin combined with cytotoxic or immune-oncology agents.
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.